• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ralf Gold - Articles and news items

Biogen Idec logo

New Tecfidera® (Dimethyl Fumarate) data show stustained efficacy and long-term safety in a broad range of Multiple Sclerosis

Industry news / 4 October 2013 / Biogen Idec

Interim results from ENDORSE extension study reinforce favorable safety profile in patients treated for up to six and a half years…

Biogen Idec logo

The Lancet publishes SELECT study evaluating efficacy and safety of daclizumab HYP in multiple sclerosis

Industry news, News / 4 April 2013 / Biogen Idec

Results from the DAC HYP SELECT clinical trial…

Biogen Idec logo